1/45
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
what is connective tissue
1 or the 4 basic tissue types in the body (nervous, muscle, epithelial, and connective tissue)
what is the purpose of connective tissue
-protects (skeletal)
-supports
-binds (anchor in the body -ex:GI)
-transport (blood -O2 and nutrients, waste)
-immunity (lymphatic - WBC)
what are the 5 types of specialized connective tissue
-bone
-adipose
-cartilage
-blood
-reticular
what are the 3 things that make up connective tissue
cells, fibers and extracellular matrix
what are symptoms of connective tissue disorder
-joint pain and stiffness
-muscle weakness
-skin rashes or texture changes
-organ dysfunction and/or damage
*symptoms are everywhere there is CT
what are the non-specific constitutional symptoms of connective tissue disorder
-fatigue
-SOB
-malaise
-fever
-weight loss
do all patients with connective tissue disorders have the same symptoms
no
what pattern can be seen with connective tissue disorders
relapse/remit
-can have acute worsening
____ diagnosis is crucial for best outcome
early
what are the 2 subcategories of connective tissue diseases
inherited
autoimmune
what are the types of inherited connective tissue disorders
-ehlers-danlos syndrome
-marfan syndrome
-osteogenesis imperfecta
what are the types of autoimmune connective tissue diseases
-systemic lupus erythematosus (SLE)
-polymyositis and dermatomyositis
-scleroderma
-rheumatoid arthritis (RA)
-sjogren’s syndrome
-vasculitis
-ankylosing spondylitis
-mixed connective tissue disease
lupus epidemiology
85% women
most often occurs in black women → latinas→white women
what is the onset of lupus
20-40 y/o
what is the pathology of lupus
autoimmune
likely triggered by UV light, smoking/pollution, no strong genetic markers
lupus leads to ____ lifespan and ____ QOL
shortened; worse
symptoms of lupus
Skin and Hair: photosensitivity, butterfly rash, alopecia, nail integrity, Raynauds
Heart: pleuritic chest pain, murmurs, pericarditis, myocarditis
Kidneys: inflammation, failure **poor prognosis
Joint and muscles: swollen joints, arthritis **often first sign
Mental: cog dysfunction, fever, seizures, psychosis, headaches, dizziness
Lungs: pleuritic chest pain, pneumonia, inflammation
Blood: inflammation, anemia, blood clots
Mouth: ulcers
how is lupus diagnosed
labs
tissue biopsy
what labs are taken for lupus
antinuclear antibodies (ANAs): high
CBC: low RBC, low WBC, low platelets
erythrocyte sedimentation rate (ESR): high
C-reactive protein (CRP): high
antibody labs: done for initial diagnosis
what are the medications for lupus
antimalarial meds : decrease antibodies (hydroxachloraquine)
steroids (topical or oral): decrease pain/inflamation/WBC activity (prednisone)
NSAIDS: decrease inflammation/pain (ibuprofen/naproxen)
immunosuppressives: stop immune system from attacking, organ involvement (methotrexate)
blood thinners: decrease blood clots (coumadin)
monoclonal antibodies (mAbs): protein in lab to find a substance in body
Acthar gel: decreased inflammation, help make cortisol
when is pregnancy advised for pt with lupus
when SLE is well controlled and no teratogenic meds are being used
what is the medical treatment for lupus
diet: increase vitamin B6, vitamin C. Mediterranean diet
smoking cessation
mental health support
exercise
physical therapy intervention
-variability of disease process (flares), organ involvement can make consistent activity plan challenging
-should be educating on benefits of increased activity
-environment: UV protection, layers if Raynauds
-avoid using joints that are flared - should be checked for osteonecrosis
-caution if pt is anticoagulated/thrombocytopenia
-monitor if having cardio/pulm sxs
-currently no specific outcome measure for this population
PT intervention goal
-work up to 150-300 min of moderate intensity activity (40-75% HR)
-strength 2+ days/week
-stretch
-3-5 sessions per week
polymyositis/dermatomyositis epidemiology
-women 2-3X more than men
-incidence 5-10 per 1 million per year
-prevalence 10-20 per 100,000
polymyositis/dermatomyositis onset
5-14 years and 45-65 years
polymyositis/dermatomyositis pathology
autoimmune
likely genetic predisposition, triggered by UV exposure, infection, malignancy drugs
polymyositis/dermatomyositis clinical picture
-idiopathic inflammatory myopathies
-muscle weakness and distinctive skin rash
-ILD affects 20% pts
-coexisting internal malignancy in 10-20% cases
-dysphagia (neck inflammation)
-inflammation of heart (myocarditis)
-inflammation of blood vessels of other tissues/organs such as GI, eyes, and kidneys
-symmetrical proximal weakness w/in 1 year of 80% of cases
-joint pain
dermatomyositis skin sxs
heliotrope rash: redness around eyes
gottrons papules: reddened areas on fingers
Shawl sign: plaques and patches on upper back
polymyositis/dermatomyositis weakness pattern
**hallmark sign
LEs: quads and glutes
deltoids and biceps
neck flexors
how is polymyositis/dermatomyositis diagnosed
labs
interferon (IFN): high
serum muscle enzymes (CK, lactate)
troponin for heart involvement (if CK elevated)
ANA as a rule out to lupus
myositis specific autoantibodies
screen for cancer
EMG -fibrillations
PFTs
MRI - muscle anatomy/edema
muscle biopsy
medical diagnosis of ILD
-assessed by CO of chest- “ground glass”, may have pneumonia
-respiratory failure can progress quickly (vent or ECMO)
may get severe enough for transplant
medical treatment for polymyositis/dermatomyositis
manage any malignancy or ILD first
meds
high dose oral prednisone: 1st line therapy, not effective for skin
IVIG: 1st line for skin issues, effective for myositis too
methotrexate: decrease skin issues
mycophenolate mofetil: skin and muscle issues, 1st line w/ ILD
antimalarials
topical corticosteroids
PT interventions
-exercise does NOT make pts w/ myositis worse →increases peripheral blood anti-inflammatory cytokines
cardiovascular training
increased VO2max (walking, biking)
improved mitochondrial function at the skeletal muscle
pulmonary training
wean off vent/ECMO →O2 management
diaphragmatic strengthening
strength training
concentric strength preferred, 20-30% 1RM
low load high rep
blood flow restriction is safe
scleroderma etiology
-unclear, no genetic markers
-likely driven by vascular changes
-swollen fingers and raynaud’s = edema replaced by fibrotic tissue
scleroderma epidemiology
-incidence: 1-2 per 100,000 in US
-4:1 female to male ratio
scleroderma onset
30-50 yo
scleroderma pathology
autoimmune
scleroderma clinical picture
pulmonary fibrosis/ILD, pulmonary arterial hypertension (70%)
5x increased risk of lung cancer
pericarditis, arrhythmias
7-20% have 5 year mortality rate
GI involvement (90%)
neuropathies and CNS involvement
joint pain, immobility, contractures
scleroderma “CREST” sxs
Calcinosis: calcium deposits on skin
Raynaud’s: spasm of blood vessels in response to cold/stress
Esophageal dysfunction: acid reflux and decreased motility
Sclerodactyly: thickening and tightening of skin on fingers/hands
Telangiectasias: dilation of capillaries causing red marks on skin
scleroderma medical diagnosis
skin assessment- tightness
labs
positive antinuclear antibody (ANA)
specific antibody testing
CXR and PFTs screening for pulmonary involvement
punch biopsy
scleroderma medical treatment
UVA light therapy
meds
immune modulation: high dose oral prednisone and low dose oral methotrexate
inflammation: histamine 1 and histamine 2 blockers
neuropathic pain: doxepin (oral)
education: avoid skin trauma (fingers), cold exposure, and smoking
scleroderma PT intervention
contracture management (hands, shoulders, face)
pain management
endurance training
balance training (adaptive equipment)
connective tissue disorders are most commen in
women in early-mid adulthood
commonalities of connective tissue diseases
skin involvement (each version different)
systemic involvement: lungs, heart, blood vessels, muscles, nerves
Raynauds
all connective tissue disorders use what type of meds
steroids and immunosuppression
increased risk of infection and increased risk of steroid induced muscle wasting